Stocks · News reference
Stocks in focus: SpaceX jumps after 3 launches; CL Workshop plans $200M ATM; Qualcomm files share offering; Pasqal names IR chief; Neurosense warned.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) ("NeuroSense" or the "Company"), a late-stage clinical biotechnology company focused on developing disease-modifying treatments for neurodegenerative diseases,
-SEC Filing
StoneX analyst Gary Mobley initiates coverage on Pasqal Holding (NASDAQ:PSQL) with a Buy rating and announces Price Target of $15.
Block & Leviton is investigating Lennar Corporation for potentially misleading investors about home delivery numbers in fiscal Q3 2026. The investigation focuses on whether Lennar artificially inflated delivery figures through purchases by its spinoff company Millrose Properties in the final week of the quarter. Lennar's stock fell on October 5, 2026, following an analyst downgrade of Millrose.
U.S. stock futures were lower on Monday, as the Dow Jones, S&P 500 and Nasdaq 100 indices fell, following Friday's higher close.